ActiveSite Pharmaceuticals, Inc.
Records under this name other than the patents ActiveSite Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Showing 1 to 4 of 4 · Back to ActiveSite Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,306,061 | Crystalline Forms of Plasma Kallikrein Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 12,240,818 | Crystalline Forms of Plasma Kallikrein Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 8,691,861 | Prodrugs of inhibitors of plasma kallikrein Lapsed on the fee record Ended Apr 8, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 8, 2026 | From the USPTO record |
| US 8,658,685 | Methods for treatment of kallikrein-related disorders Formerly held Lapsed on the fee record Ended Feb 25, 2022 · From the USPTO record | Lapsed on the fee record | Ended Feb 25, 2022 | From the USPTO record |